
Medical Student @OhioStateMed. Academic interests include oncology, molecular biology and medical education. All opinions and tweets are my own.
Columbus, OH
Joined April 2023
- Tweets8
- Following98
- Followers27
- Likes48
Stephen Andrews retweeted
Replying to @AndrewsStephenG
@AndrewsStephenG et al. @NCICCR_SurgOnc @theNCI
provide a detailed discussion of the utilisation and limitations of small #intestinal #neuroendocrine #tumours models and address areas of future research in this field. Read it here 👉doi.org/10.1530/EO-24-0038
Happy to work with such a great team on this review of siNET models, focusing on new technologies!!!
Looking for a detailled summary on models for small bowel #NET 👇🎯🎯 @AndrewsStephenG @StevenDForsythe @JimMadigan3 from my lab wrote a great review @NCICCR_SurgOnc @theNCI eo.bioscientifica.com/view/j…
6
140
Feeling energized by science over the last three days #ENDO2024 @TheEndoSociety key highlights were updates in molecular mechanisms of hormone-dependent cancers, new tech to study TME in endocrine cancers, and models for PPGL!
Looking forward to ENDO 2025!!
This opportunity would not be possible without the endocrine team @NCICCR_SurgOnc @samira_sadowski @StevenDForsythe @JimMadigan3 Dr. Naris Nilubol and many others!
So thankful for the opportunity to present our work and learn from so many amazing researchers and colleagues throughout my fellowship @NCIResearchCtr @samira_sadowski @JimMadigan3 @StevenDForsythe see you at ENDO 2025 @TheEndoSociety
And…congratulations 👏👏@AndrewsStephenG for winning the rapid fire stars talk in the translational research category! #ENDO2024 @TheEndoSociety @NCIResearchCtr @NCICCR_SurgOnc
Stephen Andrews retweeted
Proud of my research team 🎯👇 Postdoc @StevenDForsythe expert in #NET models and postbac @AndrewsStephenG presenting his single cell ATACseq data in matched #smallbowel #NET @NCIResearchCtr @NCICCR_SurgOnc @NANETS1 @CureNETs
This Post is from an account that no longer exists. Learn more
Stephen Andrews retweeted
New from Surgeon-Scientist Dr. Samira Sadowski's lab:
Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model aacrjournals.org/mct/article…











